These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 6831420

  • 41. Comparative intraosseal growth of human prostate cancer cell lines LNCaP and PC-3 in the nude mouse.
    Soos G, Jones RF, Haas GP, Wang CY.
    Anticancer Res; 1997; 17(6D):4253-8. PubMed ID: 9494517
    [Abstract] [Full Text] [Related]

  • 42. Regression of LNCaP human prostate tumor xenografts in athymic nude mice by 13-cis-retinoic acid and androgen ablation.
    Dahiya R, Zhang DY, Ho RJ, Haughney PC, Hayward SW, Cunha GR, Narayan P.
    Biochem Mol Biol Int; 1995 Mar; 35(3):487-98. PubMed ID: 7773185
    [Abstract] [Full Text] [Related]

  • 43. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
    Gleave M, Tolcher A, Miyake H, Nelson C, Brown B, Beraldi E, Goldie J.
    Clin Cancer Res; 1999 Oct; 5(10):2891-8. PubMed ID: 10537358
    [Abstract] [Full Text] [Related]

  • 44. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 45. Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice.
    Bénard J, Da Silva J, De Blois MC, Boyer P, Duvillard P, Chiric E, Riou G.
    Cancer Res; 1985 Oct 15; 45(10):4970-9. PubMed ID: 3861241
    [Abstract] [Full Text] [Related]

  • 46. Characterisation of a human endometrial adenocarcinoma established in vivo and in vitro.
    Karlsson L, Leser G, Ryd W, Delle U, Köpf I, Horvath G.
    In Vivo; 1996 Oct 15; 10(4):421-8. PubMed ID: 8839789
    [Abstract] [Full Text] [Related]

  • 47. Characterization and development of UCI 107, a primary human ovarian carcinoma cell line.
    Gamboa G, Carpenter PM, Podnos YD, Dorion G, Iravani L, Bolton D, Mascarello JT, Manetta A.
    Gynecol Oncol; 1995 Sep 15; 58(3):336-43. PubMed ID: 7672698
    [Abstract] [Full Text] [Related]

  • 48. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
    Webber MM, Quader ST, Kleinman HK, Bello-DeOcampo D, Storto PD, Bice G, DeMendonca-Calaca W, Williams DE.
    Prostate; 2001 Apr 15; 47(1):1-13. PubMed ID: 11304724
    [Abstract] [Full Text] [Related]

  • 49. Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties.
    Gorai I, Nakazawa T, Miyagi E, Hirahara F, Nagashima Y, Minaguchi H.
    Gynecol Oncol; 1995 Apr 15; 57(1):33-46. PubMed ID: 7535723
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF.
    Endocr Relat Cancer; 2006 Mar 15; 13(1):151-67. PubMed ID: 16601285
    [Abstract] [Full Text] [Related]

  • 52. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.
    Prostate; 2006 Jul 01; 66(10):1070-5. PubMed ID: 16637076
    [Abstract] [Full Text] [Related]

  • 53. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB, Isaacs JT.
    Cancer Res; 1997 Mar 15; 57(6):1054-7. PubMed ID: 9067270
    [Abstract] [Full Text] [Related]

  • 54. [In vitro and in vivo models developed from human prostatic cancer].
    Bladou F, Gleave ME, Penault-Llorca F, Serment G, Lange PH, Vessella RL.
    Prog Urol; 1997 Jun 15; 7(3):384-96. PubMed ID: 9273065
    [Abstract] [Full Text] [Related]

  • 55. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ.
    Prostate; 2009 May 01; 69(6):610-23. PubMed ID: 19143029
    [Abstract] [Full Text] [Related]

  • 56. Serial transplantation to nude mice of an androgen-dependent pilosebaceous tumor developed in Suncus murinus.
    Itami S, Takayasu S.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5666-9. PubMed ID: 6498827
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Establishment and characterization of a new human functional cell line from a choriocarcinoma.
    Okabe T, Sasaki N, Matsuzaki M, Imai Y, Kaneko Y, Matsuzaki F, Takaku F, Tsushima T.
    Cancer Res; 1983 Oct 01; 43(10):4920-6. PubMed ID: 6603906
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.